{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380004236357144192.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Ching-Ling Lin"}],"foaf:familyName":[{"@value":"Lin"}],"foaf:givenName":[{"@value":"Ching-Ling"}]}],"career":[{"institution":{"notation":[{"@value":"Department of Endocrinology and Metabolism, Cathay General Hospital, Taipei, Taiwan"}]}},{"institution":{"notation":[{"@value":"Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360004236357144192","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1155/2018/3835783"},{"@type":"URI","@value":"http://downloads.hindawi.com/journals/dm/2018/3835783.pdf"},{"@type":"URI","@value":"http://downloads.hindawi.com/journals/dm/2018/3835783.xml"}],"notation":[{"@value":"CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1155/2018/3835783_IqJPWviMUuC5tPovMvuGdsuBFi5"}]}